Revivo Therapeutics Announces Advisory Board Members Following Substantial Interest by Thought Leaders in R&D and Clinical Development

Dr. Doug Cowart, CEO and Dr. John Reardon, CSO of Revivo Therapeutics announced the company has completed the formation of its advisory board, which consists of leaders in both preclinical and clinical development of therapeutics directed at Alzheimer’s disease therapies.